DOT1L probes

Patent metadata

Field	Value
Publication number	US-9535067-B2
Application number	US-201414904572-A
Country	US
Kind code	B2
Filing date	Jul 28, 2014
Priority date	Jul 29, 2013
Publication date	Jan 3, 2017
Grant date	Jan 3, 2017

Abstract

The present invention relates to compound that bind Histone H3-lysine79 (H3K79) methyl transferase (DOTIL). The disclosed compounds are useful as for assessing the activity of DOTIL and for identifying inhibitors of DOTIL. Described herein are probes useful for both assessing the activity of DOTIL and identifying inhibitors of DOTIL. These probes can be used in various assays, including Amplified Luminescent Proximity Homogeneous Assays (“ALPHA” assays), Differential Scanning Fluorimetry (DFS) Assay, and Fluorescence Polarization (FP) assays used for high-throughput screening (HTS) for small molecule drug discovery. The compounds can also be used as a pull down agent for target identification.

First claim

What is claimed is:

1. A probe, comprising a compound having formula (I):

wherein:
X is N or C—R5;
Y is O or S;
R1 is hydrogen or C 1-3 alkyl;
R2 is hydrogen, C 1-3 alkyl, or R6;
R3 is hydrogen, C 1-6 alkyl, or R6;
R4 is C 1-8 alkyl, or N(R6)(R7), provided that one of R2, R3, and R4 is, or includes, R6;
R5 is hydrogen, halo, C 1-6 alkyl, or C 1-6 haloalkyl;
R6 is Z—R8;
Z is a divalent group consisting of any 1, 2, 3, 4, or 5 of the following independently selected moieties:
(i) C 1-30 alkylene;
(ii) heteroalkylene that spans from 3-20 atoms in length wherein from 1-8 of the atoms in the span are heteroatomic groups that are each independently selected from N, NH, N—C 1 -C 6 alkyl, O, and S, provided that there is at least one carbon atom between the occurrence of any two heteroatomic groups;
(iii) polyheteroalkylene chain that spans from 21-100 atoms in length wherein from 1-50 of the atoms in the span are heteroatomic groups that are each independently selected from N, NH, N—C 1 -C 6 alkyl, O, and S, provided that there is at least one carbon atom between the occurrence of any two heteroatomic groups;
(iv) C 2-30 alkenylene chain; and
(v) —OC(═O)—, —C(═O)O—, —NHC(═O)—, —C(═O)NH—, —NHC(═O)NH—, —NHC(═S)NH—, —OC(═O)NH—, and —NHC(═O)O—;

R7 is hydrogen or C 1-3 alkyl; and
R8 is an affinity tag or a fluorescent label.

2. The probe of claim 1 , wherein R2 is R6.

3. The probe of claim 1 , wherein R3 is R6.

4. The probe of claim 1 , wherein R4 is N(R6)(R7).

5. The probe according to claim 1 , wherein R8 is an affinity tag.

6. The probe according to claim 1 , wherein R8 has an affinity for streptavidin.

7. The probe according to claim 1 , wherein R8 has formula (II):

8. The probe according to claim 1 , wherein R8 is a fluorescent label.

9. The probe of claim 4 , wherein R8 is FITC.

10. The probe according to claim 1 , wherein Z is a divalent group consisting of one, two, three, four, or five groups independently selected from the group consisting of C 1-30 alkylenes; a heteroalkylene or polyheteroalkylene; —NHC(═O)—, —C(═O)NH—, and —NHC(═S)NH—.

11. The probe of claim 10 , wherein the polyheteroalkylene is (PEG)n, wherein PEG represents a polyethylene glycol, and n is an integer from 2-27.

12. The probe according to claim 1 , wherein R3 is C 1-6 alkyl.

13. The probe according to claim 1 , wherein R4 is C 1-8 alkyl.

14. The probe according to claim 1 , wherein R2 is hydrogen.

15. The probe of claim 1 , wherein the compound is selected from the group consisting of:

16. The probe according to claim 1 , wherein the probe further comprises a solid support.

17. The probe of claim 16 , wherein the solid support is a bead.

18. The probe of claim 17 , wherein the bead is coated with a protein.

19. The probe of claim 18 , wherein the protein is streptavidin.

20. The probe of claim 1 , wherein the compound is selected from the group consisting of:

wherein:
n is 2-27;
n′ is 0-10;
X is N, CH, C—Cl, C—CH 3 , or C—CF 3 ;
Y is O or S; and
R is t-butyl or methyl.

21. The probe of claim 1 , wherein the compound is selected from the group consisting of:

wherein:
X is N or C—R5;
R5 is hydrogen, halo, C 1-6 alkyl, or C 1-6 haloalkyl;
Y is O or S; and
R is t-butyl or methyl.

Assignees

• Dana Farber Cancer Inst Inc

Inventors

• Bradner James E
• Federation Alexander
• Qi Jun

Classifications

• G01N33/582

  with fluorescent label · CPC title

• G01N2500/02

  Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor) · CPC title

• G01N2333/91017

  with definite EC number (2.1.1.-) · CPC title

• A61K31/7076

  containing purines, e.g. adenosine, adenylic acid · CPC title

• C07H19/16

  Purine radicals · CPC title